FreeFree RFPs on Craxy AI — no subscription required

Ready to bid on this RFP?

Sign up free to generate a complete proposal draft instantly — Craxy AI reads the RFP, drafts every section, and matches your past work.

Early Investigator Research Award Service

Washington, DCDistrict of Columbia, USADue Friday, November 6, 2026
Client
Washington, DC
RFP Number
DRA-10921
Posted
6/19/2026
Category
Data Research and Analytics
Budget
Looking for Proposals
NAICS
—
Set-aside
—
Contact
—

Description

AI Generated

The government authority located in Washington, DC, is seeking early investigator research award services to advance the understanding and treatment of Parkinson's disease. The agency is trying to solve critical knowledge gaps by funding research into biological mechanisms or biomarkers, including clinical, fluid, imaging, tissue, and device indicators, that address unmet medical needs. This initiative aims to drive the development of novel treatments for Parkinson's disease across all stages, from prodromal to late-stage disease. The scope of work covers the development and characterization of in vitro model systems that approximate in vivo cellular and system complexity. Additionally, the project requires investigating how disease biological and clinical heterogeneity impacts disease presentation, clinical course, and therapeutic outcomes. The agency requires all performed work to take place offsite. Eligibility is strictly limited to onshore organizations based in the United States. The agency is currently looking for proposals to determine the budget and has not disclosed a specific funding limit or key dates in the initial solicitation. Evaluation will be based on the submitted proposals addressing these research areas.

Key solicitation details

AI-extracted from DRA 10921 2026 06 19 09 44 31 7hF66 sCcHE 99nEA.pdf. Confirm against the original documents before bidding.

The Defense Health Agency is soliciting applications for the FY26 Parkinson's Research Program Early Investigator Research Award to support Parkinson's disease research conducted by early-career investigators. The award offers two funding levels with total cost caps of $0.3M and $1.0M over a maximum 2-year period. Extramural and intramural organizations, including foreign, domestic, for-profit, non-profit, public, and private entities, are eligible to apply.

Issued by
Defense Health Agency Contracting Activity
Pre-Application (Letter of Intent) Submission Deadline
5:00 p.m. Eastern Time (ET), October 23, 2026
Application Submission Deadline
11:59 p.m. ET, November 6, 2026
End of Application Verification Period
5:00 p.m. ET, November 13, 2026
Confidential Letters of Recommendation Submission Deadline
5:00 p.m. ET, November 13, 2026
Peer Review
January 2027
Programmatic Review
March 2027
How to submit
Electronic via eBRAP and Grants.gov Workspace
Submission details
Pre-applications must be submitted via eBRAP. Full applications for extramural organizations must be submitted via Grants.gov Workspace, and intramural DOW organizations submit via eBRAP.
Contract term
Maximum period of performance is 2 years.
Estimated value
Roughly $4.2M total allotment for approximately seven awards; $0.3M total cost cap for Funding Level 1 and $1.0M for Funding Level 2.
Place of performance
Offsite
Funding
Defense Health Agency Parkinson's Research Program, Assistance Listing Number 12.420, 10 USC 4001, 2 CFR 200

How proposals are evaluated

Scored Peer Review Criteria (Technical Merit)
Mentor(s) (required for Funding Level 1)
Researcher Development Plan (required for Funding Level 1)
Unscored Criteria including Budget

Scope of work

  • Development and characterization of in vitro model systems that approximate in vivo cellular and system complexity
  • Understanding how disease biological and clinical heterogeneity impacts disease presentation, clinical course and therapeutic outcomes
  • Identification of biological mechanisms or biomarkers of unmet medical needs that could lead to treatment development
  • Interventions addressing unmet medical needs of Parkinson's disease across clinical and preclinical models

Minimum qualifications

  • Postdoctoral fellows, clinical fellows, or independent investigators within 10 years of advanced degree or residency training completion
  • Active SAM.gov, eBRAP.org, and Grants.gov registrations prior to application preparation
  • Funding Level 1 applications require at least one designated mentor with PD research and mentoring experience
  • An investigator may be named as PI on only one FY26 PRP EIRA application

Documents to include with the bid

  • SF424 Research & Related Application for Federal Assistance Form
  • Attachment 1: Project Narrative
  • Attachment 2: Supporting Documentation
  • Attachment 3: Technical Abstract
  • Attachment 4: Lay Abstract
  • Attachment 5: Statement of Work
  • Attachment 6: Impact Statement
  • Attachment 7: Letter of Eligibility
  • Attachment 8: Research Outcomes Plan
  • Attachment 9: Researcher Development Plan (Funding Level 1)

Verify important details

Document check

Confirm submission instructions and amendments with the issuing agency before responding.

1 available fileDocuments checked

Personalized fit score

Sign up free to see how well this opportunity fits your company — based on your saved profile.

Sign up to see your fit score